A novel antiangiogenic effect for telomerase-specific virotherapy through host immune system.
Ikeda Y, Kojima T, Kuroda S, Endo Y, Sakai R, Hioki M, Kishimoto H, Uno F, Kagawa S, Watanabe Y, Hashimoto Y, Urata Y, Tanaka N, Fujiwara T.
Ikeda Y, et al. Among authors: endo y.
J Immunol. 2009 Feb 1;182(3):1763-9. doi: 10.4049/jimmunol.182.3.1763.
J Immunol. 2009.
PMID: 19155526